2013
DOI: 10.1016/j.medcli.2012.05.034
|View full text |Cite
|
Sign up to set email alerts
|

Diabetes mellitus gestacional y etnia materna: alta prevalencia de macrosomía fetal en mujeres no caucásicas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
3
0
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 28 publications
1
3
0
1
Order By: Relevance
“…Racial disparities in perinatal outcomes among women with and without diabetes have also been described and some authors have even suggested a lower risk of adverse pregnancy outcomes in groups at high risk of GDM [20]. Several reports have found ethnic differences in the incidence of macrosomia and LGA and some of them indicate a higher risk in Latin American and Moroccan women [17,18,30] and a lower risk among South Central Asian women [31,32]. Our results are in general agreement with those of previous studies.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…Racial disparities in perinatal outcomes among women with and without diabetes have also been described and some authors have even suggested a lower risk of adverse pregnancy outcomes in groups at high risk of GDM [20]. Several reports have found ethnic differences in the incidence of macrosomia and LGA and some of them indicate a higher risk in Latin American and Moroccan women [17,18,30] and a lower risk among South Central Asian women [31,32]. Our results are in general agreement with those of previous studies.…”
Section: Discussionsupporting
confidence: 92%
“…In this regard, Hartland et al assessed trimester-and ethnic group-related reference ranges for HbAlc in Caucasian and Asian pregnant women without diabetes and reported significantly higher levels among Asians [16]. On the other hand, ethnic differences have also been described in terms of obstetric results [17,18] and in the interrelationship between hyperglycaemia and pregnancy outcomes [19][20][21].…”
Section: Introductionmentioning
confidence: 99%
“…Other variables were also studied: region of origin (Sub Saharian Africa, Latin America, Asia and the Middle East, West Europe, Eastern Europe, and Maghreb) (19); body mass index (BMI); number of pregnancy and twin pregnancy; abortions; prolonged or pre-term delivery; cesarean section; diabetes mellitus (code O24.9 at CIE-10. ); arterial hypertension (code I10-I16 at l'ICD-10); dyslipidemia (code E78 at l'ICD-10); depression (codes F32.0-F32.9, F33.0-F33.3, F33.8, F33.9, F34.1, or F41.2 at l'ICD-10); preeclampsia; risk during pregnancy; newborn weight, classified as low weight (<2500 gr), normal weight (2500-4000 gr), and macrosomia (>4000 gr) (20); and score of the Apgar test in the first minute and in the fifth, classified as good when ≥7 points and bad when <7 points (21).…”
Section: • Materials and Methodsmentioning
confidence: 99%
“…); arterial hypertension (code I10-I16 at l'ICD-10); dyslipidemia (code E78 at l'ICD-10); depression (codes F32.0-F32.9, F33.0-F33.3, F33.8, F33.9, F34.1, or F41.2 at l'ICD-10); preeclampsia; risk during pregnancy (this classification is what is used in the real practice in Lleida Region Health, on the one hand we can categorised low risk and medium risk as "low risk". On the other hand we can categorised high risk and very high risk as "high risk); newborn weight, classified as low weight (<2500 gr), normal weight (2500-4000 gr), and macrosomia (>4000 gr) [19]; score of the Apgar test in the first minute and in the fifth, classified as good when �7 points and bad when <7 points [20]; and therapeutic adherence, we defined three levels of therapeutic adherence, as we observed in other studies: high, for patients who took more than 80% of the drug prescribed; medium, for those who took between 50 and 80%; and low, for those who took <50% [17]).…”
Section: Plos Onementioning
confidence: 99%